Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allakos Inc (NQ: ALLK )

1.020 +0.010 (+0.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 433,538
Open 1.030
Bid (Size) 1.020 (20)
Ask (Size) 1.070 (3)
Prev. Close 1.010
Today's Range 0.9807 - 1.030
52wk Range 0.9799 - 5.640
Shares Outstanding 86,560,315
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning! 
Via InvestorPlace
3 Biotech Stocks to Dump Before They Go to Zero
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling. 
Via InvestorPlace

Performance

YTD
-62.77%
-62.77%
1 Month
-20.31%
-20.31%
3 Month
-21.54%
-21.54%
6 Month
-42.05%
-42.05%
1 Year
-75.83%
-75.83%

More News

Read More
ALLK Stock Earnings: Allakos Misses EPS for Q4 2023
Via InvestorPlace
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
From Allakos Inc.
Via GlobeNewswire
Where Allakos Stands With Analysts
Via Benzinga
What 4 Analyst Ratings Have To Say About Allakos
Via Benzinga
Why Shares of Allakos Are Up Wednesday
Via The Motley Fool
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
From Allakos Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
From Allakos Inc.
Via GlobeNewswire
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Gold Down 1%; PNC Financial Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Is Allakos (ALLK) Stock Down 57% Today?
Via InvestorPlace
Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50%
Via Benzinga
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Allakos Announces a Restructuring to Focus on Development of AK006
From Allakos Inc.
Via GlobeNewswire
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
From Allakos Inc.
Via GlobeNewswire
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
Via Benzinga
Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results
From Allakos Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.